NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SHINE Technologies

SHINE Technologies

Private
Janesville, WisconsinHealthcare & Life Scienceshttps://www.shinefusion.com/

Last Round

Debt

Apr 9, 2026

Total Funding Raised

$944.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

SHINE Technologies is a nuclear technology company that develops fusion-based neutron sources for medical isotope production, industrial imaging, and radiation effects testing, with a long-term goal of generating clean fusion energy.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Biotech Equipment, Waste Management, Renewable Energy

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Non-AI

Keywords

medical isotopesfusion technologynuclear medicineSPECT imagingLutetium-177nuclear waste managementneutron generationMolybdenum-99radiochemistryisotope supply chainfusion energytheranosticsneutron testingnuclear techdeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SHINE Technologies Comparables

Compare SHINE Technologies with similar companies based on industry and business-model similarity.

SHINE Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NorthStar Medical Radioisotopes, LLC
89%
Nusano
82%
Niowave Inc.
82%

SHINE Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtApr 9, 2026
Series EFeb 26, 2026
GrantFeb 12, 2025
GrantJul 17, 2024
Convertible DebtOct 11, 2023
Series C
Jun 28, 2021

Key People

Founding team and executive leadership

Chris Lee

Chief Financial Officer

Executive Team

Eli Moll

Chief Operating Officer

Executive Team

SHINE Technologies Investors

Notable investors and investment history

SHINE Technologies investors
InvestorRounds
Deerfield ManagementSeries E, Series B, Debt
Affiliates of Oaktree Capital ManagementPrivate Equity
NantWorksSeries E
Fidelity Management & Research CompanySeries C, Series E, Convertible Debt
Pelican Energy PartnersSeries E
Koch Disruptive TechnologiesSeries C
Sumitomo Corporation of AmericasSeries E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 30, 2026

    Chrysalis Moly 99 facility in Janesville, WI is in buildout and commissioning.

  • Apr 30, 2026

    Ilumira brand name disclosed for Lu-177 isotope commercial business.

SHINE Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SHINE Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SHINE Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersJanesville, Wisconsin
Employee Range344
Year Founded2010
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.